Basal cell neoplasms are a common type of skin cancer that can be identified by their characteristic appearance. The word 'basal' is spelled as /ˈbeɪs(ə)l/, and refers to the lower layer of tissue in the skin. 'Cell' is spelled as /sɛl/ and refers to the smallest functional unit of the skin tissue. 'Neoplasms' is spelled as /niːəʊˌplæz(ə)mz/ and refers to the growth of abnormal cells in the skin. Proper spelling and understanding the pronunciation of medical terms is important for all healthcare professionals.
Basal cell neoplasms refer to a group of abnormal growths or tumors that originate from the basal cells, which are a type of skin cell located in the lower layer of the epidermis. Basal cells are responsible for producing new skin cells and play a crucial role in maintaining the integrity and function of the skin.
These neoplasms are typically non-cancerous or benign, and are commonly found in individuals with fair skin who have had prolonged exposure to sunlight or ultraviolet radiation. Basal cell neoplasms are the most common form of skin cancer, accounting for approximately 80% of all skin cancer cases.
Basal cell neoplasms usually appear as slow-growing, raised, and pink or flesh-colored lesions on the skin. They may also present as open sores or ulcers that do not heal properly, or as shiny or pearly bumps with visible blood vessels. Although they rarely metastasize or spread to other parts of the body, these tumors can cause local damage and disfigurement if left untreated.
Treatment options for basal cell neoplasms depend on various factors, including the location, size, and subtype of the tumor, as well as the individual's overall health. Common treatment methods include surgical excision, Mohs surgery (a precise method to remove cancerous tissue layer by layer), cryotherapy (freezing the tumor), radiation therapy, or topical medications. Regular monitoring and follow-up with healthcare professionals are essential to detect any recurrence or new lesions, as individuals who have had basal cell neoplasms are at an increased risk of developing additional skin cancers.